ACHE and migraine disorder: The therapeutic benefit of acetylcholinesterase inhibitor drugs such as donepezil in migraine (Ikeda et al. 2009; Nicolodi et al. 2002) suggests that cholinergic pathways may suppress migrainous attacks and, thus, muscarinic cholinergic receptor antagonists might lead to the development of headache.